Is CoreWeave a Buy 1 Year After Its IPO?
CoreWeave has experienced ups and downs over the past year.
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
Bitcoin bulls avoided a correction as US markets opened, but analysis warned that Strategy was responsible for much of the latest BTC price strength.
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse Articles
CoreWeave has experienced ups and downs over the past year.
The Amazon founder says most investors fall short because they focus on the short term.
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not al...
ECB Backs ESMA Crypto Supervision: What It Means for MiCA The post ECB Backs ESMA-Led Crypto Supervision in EU: Tighter MiCA Enforcement Incoming appeared...
Apple tops global smartphone market for first time in Q1 2026
Dividend-paying companies outperform those that don't pay dividends by a considerable margin.
Sodexo cuts 2026 targets as new CEO gears to tackle long-standing issues
Semiconductors get a massive upgrade, but contemplating the risks to chipmakers suggests how the AI hype train might stall or even disintegrate.
Electric trucks are gaining ground as diesel costs rise âEUR" but high prices, limited charging and infrastructure gaps mean the transition is far from com...
The Strait of Hormuz crisis is not an aberration from the new geopolitical order - it is an expression of it and investors need to adjust to this fast, say...
STOXX 600 set for third weekly gain as investors eye US-Iran talks
Organon shares surge 8.4% on report of Sun Pharma's $12 billion bid